The Cannabinoid Receptor Agonist WIN 55,212-2 Reduces D 2 , but Not D 1 , Dopamine Receptor-Mediated Alleviation of Akinesia in the Reserpine-Treated Rat Model of Parkinson's Disease

By Maneuf Y.P.   Crossman A.R.   Brotchie J.M.  

Experimental Neurology, Vol. 148, Iss. 1, 1997-11 ,pp. : 265-270

Elsevier

Access to resources Recommend Favorite

The Cannabinoid Receptor Agonist WIN 55,212-2 Regulates Glutamate Transmission in Rat Cerebral Cortex: an In Vivo and In Vitro Study

By Ferraro L.   Tomasini M.C.   Gessa G.L.   Bebe B.W.   Tanganelli S.   Antonelli T.  

Cerebral Cortex, Vol. 11, Iss. 8, 2001-08 ,pp. : 728-733

Oxford University Press

Access to resources Recommend Favorite

Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model

By Stratton S.C.   Large C.H.   Cox B.   Davies G.   Hagan R.M.  

Epilepsy Research, Vol. 53, Iss. 1, 2003-02 ,pp. : 95-106

Elsevier

Access to resources Recommend Favorite

Effects of the GABA Receptor Agonist Phenibut on Spike Activity and Interactions between Neocortex and Hippocampus Neurons in Emotionally Negative Situations

By Zyablitseva E.   Pavlova I.  

Neuroscience and Behavioral Physiology, Vol. 40, Iss. 9, 2010-11 ,pp. : 1003-1011

Springer Publishing Company

Access to resources Recommend Favorite

Effects of an Agonist of β2 Adrenoreceptors on Reactions of Pyramidal Neurons of Area CA1 of the Rat Hippocampus Modified Due to Blocking of GABA_A Receptors

By Roman’ko A.   Razoumnaya N.  

Neurophysiology, Vol. 45, Iss. 4, 2013-07 ,pp. : 289-292

Springer Publishing Company

Access to resources Recommend Favorite